missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Promega ApoLive-Glo™ Multiplex Assay 
The ApoLive-Glo™ Multiplex Assay measures both the number of viable cells as a marker of cytotoxicity and caspase activation as a marker of apoptosis within a single assay well to determine the mechanism of cell death.
$1017.19 - $3433.67
Specifications
| Detection Method | Fluorescence, Luminescence |
|---|---|
| For Use With (Application) | Profile Compounds for Cytotoxic Risk |
| Format | Bottle |
| Content And Storage | -30°C to -10°C |
Includes: GF-AFC Substrate, Assay Buffer, Caspase-Glo 3/7 Buffer, Caspase-Glo 3/7 Substrate
Description
- Measure Viability and Apoptosis in the Same Sample Well
- Accurately determine mechanism of cell death in less time, with less sample
- Easy to implement using a simple sequential 'add-mix-measure' protocol
- Adaptable to meet various throughput needs
Specifications
| Fluorescence, Luminescence | |
| Profile Compounds for Cytotoxic Risk | |
| Bottle | |
| -30°C to -10°C |
- U.S. Patents 7,416,854; 7,553,632 and other patents pending.
- U.S. Patents 6,602,677 and 7,241,584, Australian Patents 754312 and 785294 and other patents and patents pending.
- U.S. Patents 7,148,030 and 7,384,758, Australian Patent 2003216139 and other patents pending.
- The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024, 5,674,713 and 5,700,673.